Indiana

CONSTRUCTION PROJECTS

Major Projects ($5M+) 2019-2024

Indiana Fact Sheet, 2019-2024

Pharmaceutical & Biotech Mfg and R&D

Number of Major Projects

($5+ million)

Major Project Valuation

(Any major project active
between 2019 and 2024)

$12.42 billion

Total Construction Spending

(Capital and maintenance
expenditure, 2019-2024)

$6.66 billion

Largest Construction Projects, Pharmaceutical and Biotech Manufacturing and R&D, 2019-2024

Project Owner		Project City	State	Years	Value
Eli Lilly & Company	Lebanon Grassroot (APIS) LP1 Production Buildings (LP131/ LP130) Campus Plant 1	Lebanon	IN	2023-28	$7,700 million
Eli Lilly & Company	Lebanon Active Pharmaceutical Ingredients (APIS) (LP1) Campus Expansion Plant	Lebanon	IN	2023-27	$600 million
Eli Lilly & Company	Lebanon Grassroot Cell and Gene Therapies LP2 Leap Campus	Lebanon	IN	2023-27	$500 million
Eli Lilly & Company	Indianapolis Ltc South Insulin RDNA Injectable Aseptic Filling Bld K115 Addition	Indianapolis	IN	2023-25	$350 million
Catalent Pharma Solutions Incorporated	Bloomington Biologics Fill/Finish & Lyophilization CDMO Capacity Expansion	Bloomington	IN	2023-25	$300 million
Simtra BioPharma Solutions	Bloomington Sterile Fill-Finish and Injectables CDMO Plant Building H Addition	Bloomington	IN	2023-26	$250 million
Eli Lilly & Company	Indianapolis Ltc South Insulins K132C Purification Project Building Addition	Indianapolis	IN	2022-24	$240 million
Evonik Corporation	Lafayette Tippecanoe MRNA Based Lipids Production Building Addition	Lafayette	IN	2023-25	$220 million
Catalent Pharma Solutions Incorporated	Bloomington Biologics CMO Bldg B Fill/Finish Line #1 Addition (Project Pegasus)	Bloomington	IN	2022-24	$130 million
Eli Lilly & Company	Indianapolis Ltc South Insulin RDNA Injectables & APIS K-116 Plant Expansion	Indianapolis	IN	2023-25	$125 million

SCROLL TABLE

Indiana

CONSTRUCTION EMPLOYMENT

Industry Analysis:

Indiana

Pharmaceutical
Manufacturing

(NAICS = 325400)

Firms:

109

Employees:

22,639

Annual Wages:

$3.69 billion

Wages per Employee:

$163,008

Construction Labor Overview, 2019-2024

Pharmaceutical & Biotech Mfg and R&D

Total Labor Hours

(14 trades; installation and maintenance)

13,391,633

Union Labor Hours (est.)

(Estimated state union% in non-residential blue-collar construction trades = 50.7% )

5,235,476

Union Earnings (est.)

$183,075,641

Data Sources

Pharmaceutical and biotech industry data (projects, spending, labor hours demanded) from Industrial Information Resources (IIR). State industry employment data from the Bureau of Labor Statistics (QCEW) using the North American Industry Classification System (NAICS). State union percent in non-residential construction calculated by dividing union members in construction (unionstats.com) by blue-collar QCEW employment in nonresidential construction firms in 2019 (assumes union density equals zero in residential construction; blue-collar percentage from NAICS=23 using the BLS Occupational Employment Statistics series). Note: Pharmaceutical manufacturing industry statistics (above) do not represent the entirety of the pharmaceutical and biotech industry featured in this study. Most significantly, in addition to NAICS 325400 (“Pharmaceutical Manufacturing”), other industry jobs comprise a subset of NAICS 541700 (“Scientific R&D Services”).

Construction Labor Overview, 2019-2024

Pharmaceutical & Biotech Mfg and R&D

	Installation	Maintenance	Total
Boilermaker	145,641	20,186	165,827
Carpenter	619,997	164,416	784,413
Electrician	3,632,246	551,853	4,184,099
HVAC Installers	366,581	9,582	376,162
Instrumentation Tech	2,193,970	200,311	2,394,284
Insulator	323,451	48,430	371,881
Ironworker	315,847	158,719	474,566
Laborer	689,074	61,778	750,852
Millwright	503,016	182,323	685,339
Operator	793,713	46,476	840,189
Painting	114,641	45,825	160,466
Plumber + Pipefitter	1,514,898	58,604	1,573,502
Scaffolding	262,621	31,907	294,528
Welder	224,018	111,510	335,528
Total	11,699,713	1,691,920	13,391,633

SCROLL TABLE

Indiana

Largest Construction Projects

Eli Lilly & Company

Lebanon Grassroot (APIS) LP1 Production Buildings (LP131/ LP130) Campus Plant 1

Eli Lilly & Company

Lebanon Active Pharmaceutical Ingredients (APIS) (LP1) Campus Expansion Plant

Eli Lilly & Company

Lebanon Grassroot Cell and Gene Therapies LP2 Leap Campus

Eli Lilly & Company

Indianapolis Ltc South Insulin RDNA Injectable Aseptic Filling Bld K115 Addition

Catalent Pharma Solutions Incorporated

Bloomington Biologics Fill/Finish & Lyophilization CDMO Capacity Expansion

Simtra BioPharma Solutions

Bloomington Sterile Fill-Finish and Injectables CDMO Plant Building H Addition

Eli Lilly & Company

Indianapolis Ltc South Insulins K132C Purification Project Building Addition

Evonik Corporation

Lafayette Tippecanoe MRNA Based Lipids Production Building Addition

Catalent Pharma Solutions Incorporated

Bloomington Biologics CMO Bldg B Fill/Finish Line #1 Addition (Project Pegasus)

Eli Lilly & Company

Indianapolis Ltc South Insulin RDNA Injectables & APIS K-116 Plant Expansion

Click a Card Above Location

to See Details Project Value

... Years